During the past decade, Institute for experimental and translational cardiovascular imaging conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for experimental and translational cardiovascular imaging" #1 collaborator was "Alcedis GmbH" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Johannes Gutenberg University Mainz" with 1 trials as a collaborator and "Kerckhoff Klinik" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Institute for experimental and translational cardiovascular imaging" are "Cardiomyopathies" (1 trials), "Chronic Kidney Diseases" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Disease (CAD)" (1 trials) and "Exercise Intolerance" (1 trials). Many other conditions were trialed in "Institute for experimental and translational cardiovascular imaging" in a lesser frequency.

Most popular intervention types in "Institute for experimental and translational cardiovascular imaging" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Losartan" (1 trials) and "Prednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for experimental and translational cardiovascular imaging" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Institute for experimental and translational cardiovascular imaging". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute for experimental and translational cardiovascular imaging, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute for experimental and translational cardiovascular imaging, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".